Skip to content

Effect observation of different doses of Esketamine combined with propofol in painless abortion

Effect observation of different doses of Esketamine combined with propofol in painless abortion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099544
Enrollment
Unknown
Registered
2025-03-25
Start date
2021-10-11
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless abortion

Interventions

Group A:0.1mg/kg of esketamine was administered 3 minutes before the operation, and propofol medium and long chain injection (Sichuan National Rui) was administered 3 minutes later. The operation bega
Group B:0.2mg/kg of esketamine was administered 3 minutes before the operation, and propofol medium and long chain injection (Sichuan National Rui) was administered 3 minutes later. The operation bega
Group C:0.3mg/kg of esketamine was administered 3 minutes before the operation, and propofol medium and long chain injection (Sichuan National Rui) was administered 3 minutes later. The operation bega

Sponsors

Jintang County first People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1, Age 18-40 years old, BMI(18.5-30kg/m2); 2, Routine examination is basically normal (liver and kidney function, coagulation function, blood routine, electrocardiogram, chest CT); 3, No mental disorders, mental disorders and other diseases; 4, ASA classification: I-II level; Cardiac function: Grade 1-2.

Exclusion criteria

Exclusion criteria: 1. Mental patients; 2, Esketamine drug history and allergy, or use sedative drugs and drug dependence; 3, Infectious diseases and blood system diseases; 4. Patients who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Before anesthesia (T0), at curettage (T1), and at the end of surgery (T2);Heart rate;Pulse oxygen saturation;

Secondary

MeasureTime frame
Propofol dosage;Time for eyelash reflexes to disappear;Recovery time (time from withdrawal to eye opening);Time for patient to get out of bed (PACU observation);Add the number of propofol;The number of adverse reactions;VAS pain score;

Countries

China

Contacts

Public ContactLi Deyuan

First People's Hospital of Jintang County, Sichuan Province

1839077375@qq.com+86 159 0819 8639

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026